Medicare costs estimated to top $21.1 billion for 5 years of care for elderly cancer patients

Cost estimates for cancer care are useful for the development and implementation of national cancer programs and policies. As the United States population expands and ages, the incidence of cancer and its associated costs are expected to rise.

To estimate the cost of cancer care in the U.S., Robin Yabroff, Ph.D., of the National Cancer Institute in Bethesda, Md., and colleagues used the Surveillance, Epidemiology, and End Results (SEER) and SEER-linked Medicare files to identify 718,907 cancer patients and 1,623,651 control subjects without cancer. The team subtracted the Medicare expenses for matched control subjects from the Medicare expenses for individuals diagnosed with cancer. The balance was the estimated net cost of cancer care per individual.

The mean net 5-year costs of care for elderly individuals varied widely, from less than $20,000 for patients with breast cancer or melanoma to more than $40,000 for patients with lymphoma, brain or other nervous system cancers, or cancers of the esophagus, ovaries, or stomach. Across all cancers, mean net costs were highest in the first 12 months of care and the last 12 months of life, and lowest in the period between the initial phase of care and last year of life.

Yabroff and colleagues note that the study does not evaluate the cost of care in younger cancer patients. As these individuals frequently opt for more aggressive therapies, the cost of services may differ from those reported here. Additionally, as newer, more expensive therapies become routine care, the costs could climb.

Despite these limitations, "these estimates represent a basis for projections of cancer costs that will be particularly important with the growth and aging of the U.S. population," the authors write.

In an accompanying editorial, Joseph Lipscomb, Ph.D., from Emory University in Atlanta carefully analyzes the methods used by Yabroff and colleagues and compares them with other cost-estimate approaches. The high-quality methods lead to solid, if not surprising results. "Few of these individual findings are startling; yet taken together, they provide the scientifically strongest picture yet of the incidence costs of cancer in aggregate and by tumor type for the elderly in the United States," he writes.

Source: Journal of the National Cancer Institute

CRC screening before Medicare age could save millions in federal health-care dollars
A screening program for colon cancer in patients starting ten years prior to Medicare eligibility, at age 55 instead of Medicare's 65, would save at least two dollars for every dollar spent, according to a new study presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando.
Implementation of breast health guidelines for developing countries published
A special supplement of the Oct. 15 journal Cancer for the first time details guidelines for low- and middle-income countries to implement breast cancer programs to detect and treat the most common disease among women worldwide.
Major study of opiate use in children's hospitals provides simple steps to alleviate harm
Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates. The medications block pain, but they can have nasty side effects. Constipation, for instance, is one side effect that can cause discomfort and even extend a child's hospital stay.
Are we spending too much on health?
In this poor economic climate and period of lower growth is it time to consider limiting spending on healthcare budgets? Two experts debate the issue on bmj.com today.
Disposable 'lab-on-a-chip' may save costs and lives
(PhysOrg.com) -- Low-cost, disposable cartridges that would let doctors perform diagnostic tests at the point-of-care could speed up diagnosis and treatment while lowering costs. European researchers are rapidly closing in on that goal.
Researcher micro-sizes genetics testing
Using new "lab on a chip" technology, James Landers hopes to create a hand-held device that may eventually allow physicians, crime scene investigators, pharmacists, even the general public to quickly and inexpensively conduct DNA tests from almost anywhere, without need for a complex and expensive central laboratory.
Virtual colonoscopy as good as other colon cancer screening methods
CT colonography (CTC), known as virtual colonoscopy, is as accurate at screening for colorectal cancers and pre-cancerous polyps as conventional colonoscopy, the current screening standard, according to the National CT Colonography Trial, a nationwide multi-center study that included the San Francisco VA Medical Center.
As personalized, genomic medicine takes off, four developing countries show the way for others
Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations need to foster the new science at home, says a major new Canadian study published today by Nature Publishing Group.

Medicare costs estimated to top $21.1 billion for 5 years of care for elderly cancer patients

Related stories:

News discussion: